These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9310213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Aug 22; 46(33):765-6. PubMed ID: 9272582
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Jul 11; 46(27):624-6. PubMed ID: 9218648
    [Abstract] [Full Text] [Related]

  • 6. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. From the Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    JAMA; 1997 Oct 08; 278(14):1145-6. PubMed ID: 9326464
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
    Fridkin SK.
    Clin Infect Dis; 2001 Jan 08; 32(1):108-15. PubMed ID: 11118389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Oct 11; 51(40):902. PubMed ID: 12418544
    [Abstract] [Full Text] [Related]

  • 16. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW, Cheng AC, Fowler VG, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P, Wilson KH.
    Clin Infect Dis; 2004 Apr 15; 38(8):1188-91. PubMed ID: 15095227
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct 15; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 20. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
    Phongsamart W, Srifeungfung S, Tiensasitorn C, Vanprapar N, Chearskul S, Chokephaibulkit K.
    J Med Assoc Thai; 2005 Nov 15; 88 Suppl 8():S264-8. PubMed ID: 16856450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.